New Enterprise Associates 12, Limited Partnership

CIK 1383391 · last filed 2020-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$717.36M

Companies

12

Total Filings

30

Lifetime Open-Market Net

-$299.74M

Filer Profile

Reported Address
1119 ST. PAUL STREET
BALTIMORE, MD 21202
Phone
(410) 244-0115
State of Incorporation
DE
Related Filers
NEA 12 GP, LLC — 62 joint filings, latest 2019-12-09
NEA Partners 12, Limited Partnership — 61 joint filings, latest 2019-12-09
PETER J BARRIS — 42 joint filings, latest 2019-11-29
SCOTT D SANDELL — 42 joint filings, latest 2019-11-29
FOREST BASKETT — 34 joint filings, latest 2019-11-29
PATRICK J KERINS — 30 joint filings, latest 2019-11-29
M JAMES BARRETT — 28 joint filings, latest 2018-07-25
KRISHNA KITTU KOLLURI — 28 joint filings, latest 2016-09-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARDX 10%+ Owner 8,086,401 $3.52 $28.42M $95.00M 5 2020-06-12
Tintri, Inc. (TNTR) Delisted 10%+ Owner 2,724,795 $6.49M 1 2017-07-10
Zosano Pharma Corp (ZSAN) Delisted 10%+ Owner 3,029 $0.56 $1.7K -$11.6K 1 2016-08-26
TREVENA INC (TRVN) Delisted 10%+ Owner 7,699 $0.01 $85 $40.00M 1 2014-12-10
Viracta Therapeutics, Inc. (SNSS) Delisted 10%+ Owner 22,187 $18.62 $413.1K -$8.51M 1 2014-08-29
CHANNELADVISOR CORP (ECOM) Delisted 10%+ Owner 1,661,357 $23.09 $38.36M -$321.70M 1 2013-11-13
GRPN 10%+ Owner 2,709,248 $21.48 $58.19M $0 2 2013-09-17
WDAY 10%+ Owner 2,321,212 $188.68 $437.97M $0 1 2013-04-11
FUSION-IO, INC. (FIO) Delisted 10%+ Owner 9,058,379 -$122.74M 14 2012-09-06
HYPERION THERAPEUTICS INC (HPTX) Delisted 10%+ Owner 2,206,740 $15.00M 1 2012-08-02
ECHO 10%+ Owner 2,020,219 $95.42 $192.78M $0 1 2012-03-01
ARYx Therapeutics, Inc. (ARYX) Delisted 10%+ Owner 0 -$3.26M 1 2011-03-14

Recent Filings · Page 2 of 3

30 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-09-17 GRPN Other (J) −20,000,000 $0 EDGAR
2013-08-16 GRPN Other (J) −13,000,000 $0 EDGAR
2013-04-11 WDAY Mixed $0 EDGAR
2012-09-06 FUSION-IO, INC. (FIO) Delisted Other (J) −4,500,000 $0 EDGAR
2012-08-02 HYPERION THERAPEUTICS INC (HPTX) Delisted Mixed +8,640,861 $15.00M EDGAR
2012-03-16 FUSION-IO, INC. (FIO) Delisted Other (J) −1,000,000 $0 EDGAR
2012-03-13 FUSION-IO, INC. (FIO) Delisted Other (J) −1,000,000 $0 EDGAR
2012-03-07 FUSION-IO, INC. (FIO) Delisted Other (J) −1,000,000 $0 EDGAR
2012-03-01 ECHO Other (J) −400,000 $0 EDGAR
2012-02-29 FUSION-IO, INC. (FIO) Delisted Other (J) −1,000,000 $0 EDGAR
Showing 1120 of 30
Page 2 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.